Format

Send to

Choose Destination
Gastrointest Endosc Clin N Am. 2019 Jul;29(3):447-470. doi: 10.1016/j.giec.2019.02.006. Epub 2019 Apr 5.

The Role of the Radiologist in Determining Disease Severity in Inflammatory Bowel Diseases.

Author information

1
Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, 600 South Euclid Avenue, Campus Box 8124, St. Louis, MO 63110, USA.
2
Division of Gastroenterology, NYU Langone Health, Inflammatory Bowel Disease Center at NYU Langone Health, 240 East 38th Street, 23rd Floor, New York, NY 10016, USA.
3
Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, MGH Crohn's and Colitis Center, 165 Cambridge Street, 9th Floor, Boston, MA 02114, USA. Electronic address: aananthakrishnan@mgh.harvard.edu.

Abstract

Crohn's disease and ulcerative colitis are chronic inflammatory diseases that lead to progressive bowel damage including the development of stricturing and penetrating complications. Increasingly, cross-sectional imaging with computed tomography or magnetic resonance scans have emerged as leading tools to: (1) assess disease activity; (2) monitor response to therapy or disease recurrence; and (3) identify disease-related complications. Several validated radiological scoring systems have been developed to quantify cross-sectional and longitudinal inflammatory burden in these diseases and to monitor response to treatment. Bowel ultrasound is also a simple and inexpensive tool but is operator dependent in its performance.

KEYWORDS:

Abscess; CTE; Crohn's disease; Fistula; Inflammation; MRE; Strictures; Ulcerative colitis

PMID:
31078247
DOI:
10.1016/j.giec.2019.02.006

Supplemental Content

Full text links

Icon for Elsevier Science Icon for NYU School of Medicine
Loading ...
Support Center